We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 143.00 | 151.00 | 170.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/12/2016 09:36 | No JP, stop anchoring on a share price! This is a biopharma that will multibag with any degree of success. The daily movements in the share price are meaningless for investors who bought in having read and understood the business case. Those who passively sat there when AMRYT reversed into Fastnet, without actively looking at the business, need to recognise that they must look to themselves as the problem, not others. After all, instead of doing the square root of zero, they could have sold. Buffy | buffythebuffoon | |
04/12/2016 07:42 | Now things may start to happen here. A steady upward trend to IPO level will be a start. So amryt is a trailblazer in the Irish pharmaceutical world, being the first company of its kind to secure funding from the European Investmet Bank. Not a bad point to put on the company CV. | jacksonpollack | |
03/12/2016 21:54 | As mentioned yesterday I think, Stifle (joint broker) has issued a note with a price target of 49p. I can't post the link on my phone, but if you search for 'stifle amryt' the note is available as a link from the shsreprophets website in the first result. | icebreaker | |
03/12/2016 20:14 | If the EIB is prepared to lend 20m Euro's to AMYT then I'm happy to keep holding my AMYT shares. That's good enough for me! | papillon | |
03/12/2016 12:16 | Brief mention in the Daily Mail. | bigwavedave | |
03/12/2016 09:21 | Hope so Papillion. In Aug it took nearly two weeks to get to 21 ish, so Ill be happy with same again and steady rises daily as people cotton on to the news | currypasty | |
02/12/2016 23:41 | 8th largest percentage riser on advfn today. I haven't got a crystal ball, but my gut feeling is that the AMYT share price has further to rise in the short term. I'd guess it will retest the highs of August & September. Fingers crossed! | papillon | |
02/12/2016 22:35 | Non dilutive funding from the EIB is excellent news. The share price has reacted accordingly today. Nothing more to be said except have a good weekend. | 888icb | |
02/12/2016 18:49 | ''We had the opportunity to do an equity raise but we believed that relative to the opportunity that Amryt represents, that our share price is materially undervalued right now, we felt therefore that doing an equity raise, which would be dilutive to shareholders, would be the wrong strategy.'' | currypasty | |
02/12/2016 17:05 | Interview :hTTp://www.proactiv | bigwavedave | |
02/12/2016 16:28 | Very satisfying. :-) | gnnmartin | |
02/12/2016 16:18 | Up 20% Get in! | bigwavedave | |
02/12/2016 13:12 | Good news arrives. Better late than never! The doommongers who predicted a dilutive placing in 2017 have been proved WRONG! | papillon | |
02/12/2016 11:07 | Furthermore, the lender has faith (and undoubtedly knows more than we do)!! | icebreaker | |
02/12/2016 10:54 | mr fish, because many sold, or reduced just in case a large discounted placing happened. The debt finance rules that out (probably, for now), and so people are buying back | currypasty | |
02/12/2016 10:47 | why getting credit should cause the share price to rise so much! | ali47fish | |
02/12/2016 10:41 | They only communicate when they have something significant to say (unlike bulletin board posters) ! Buffy | buffythebuffoon | |
02/12/2016 10:37 | Better news. A bit more positive now. Lack of communication was the big problem here. But if they can address that and keep pi's informed then no reason why we can't get back on the radar again and steadily move up. | jacksonpollack | |
02/12/2016 10:18 | Perhaps JP will stop whining for a few days (not including the weekend!). Patience will be rewarded. You could always sell, make some money, then come back, but the timing might be wrong. I've spoken to colleagues who are Endocrinologists and Dermatologists. I'm holding until we get the significant news... Buffy | buffythebuffoon | |
02/12/2016 10:15 | Good stuff. Very happy with that. Could see a return to the 20s. Stifel has a target price of 49p allegedly. | bigwavedave | |
02/12/2016 10:07 | Price went from 15p to 21p at start of August on nothing.. at least we have a positive rns now.. | currypasty | |
02/12/2016 09:48 | Rossannan I think we will see plenty of interest once the study starts and with it, significant share gain. Just my opinion. | icebreaker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions